The Company has chosen to fund the next stage of its journey through an SPP in order to ensure our diverse shareholder base has the opportunity to participate and benefit from the offer. The SPP structure allows capital to be raised quickly, cheaply and does not discriminate based on a shareholders status or size.
The maximum amount that a Shareholder can apply for under an SPP is $30,000. If you are interested in investing more than this amount, we encourage you to join the Company’s s708 register. Please click here for more information.
We are raising funds to drive next steps across our highly promising clinical programs. We aim to raise between $12m and $29.7m. The final level of funding raised will dictate how rapidly Race can commercially progress Zantrene.
There are three funding cases which the Company has modelled, each allows the Company to delivers a different suite of programs:
If you have additional questions about the offer, please submit your questions below and one of our Directors will be in touch with you shortlyContact Us